IL-6: A Potential Role in Cardiac Metabolic Homeostasis

被引:31
|
作者
Xu, Yitao [1 ]
Zhang, Yubin [2 ]
Ye, Junmei [2 ]
机构
[1] Imperial Coll London, Dept Surg & Canc, Div Canc, London W12 0NN, England
[2] China Pharmaceut Univ, Sch Life Sci & Technol, Dept Biochem, State Key Lab Nat Med, Nanjing 210006, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
interleukin-6 (IL-6); lipid metabolism; cardiac lipotoxicity; mitochondrial dysfunction; FATTY-ACID OXIDATION; INDUCED INSULIN-RESISTANCE; ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE; HUMAN SKELETAL-MUSCLE; OBESE ZUCKER RATS; I-KAPPA-B; LIPID-METABOLISM; INTERLEUKIN-6; GENE; ADIPOSE-TISSUE;
D O I
10.3390/ijms19092474
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-6 (IL-6) is implicated in multiple biological functions including immunity, neural development, and haematopoiesis. Recently, mounting evidence indicates that IL-6 plays a key role in metabolism, especially lipid metabolic homeostasis. A working heart requires a high and constant energy input which is largely generated by fatty acid (FA) beta-oxidation. Under pathological conditions, the precise balance between cardiac FA uptake and metabolism is perturbed so that excessive FA is accumulated, thereby predisposing to myocardial dysfunction (cardiac lipotoxicity). In this review, we summarize the current evidence that suggests the involvement of IL-6 in lipid metabolism. Cardiac metabolic features and consequences of myocardial lipotoxicity are also briefly analyzed. Finally, the roles of IL-6 in cardiac FA uptake (i.e., serum lipid profile and myocardial FA transporters) and FA metabolism (namely, beta-oxidation, mitochondrial function, biogenesis, and FA de novo synthesis) are discussed. Overall, understanding how IL-6 transmits signals to affect lipid metabolism in the heart might allow for development of better clinical therapies for obesity-associated cardiac lipotoxicity.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor?
    Pedersen, BK
    Steensberg, A
    Fischer, C
    Keller, C
    Keller, P
    Plomgaard, P
    Wolsk-Petersen, E
    Febbraio, M
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2004, 63 (02) : 263 - 267
  • [2] The role of IL-6 family cytokines in intestinal homeostasis and regeneration
    Taniguchi, Koji
    Yoshimura, Akihiko
    CYTOKINE, 2017, 100 : 104 - 104
  • [3] IL-6 and the dysregulation of immune, bone, muscle, and metabolic homeostasis during spaceflight
    Smith, John Kelly
    NPJ MICROGRAVITY, 2018, 4
  • [4] IL-6 and the dysregulation of immune, bone, muscle, and metabolic homeostasis during spaceflight
    John Kelly Smith
    npj Microgravity, 4
  • [5] Targeting IL-6 signaling as potential angiogenic and metabolic pathway
    Jung, Malte
    Boneva, Stefaniya
    Wingert, Victoria
    Schlunck, Gunther R.
    Agostini, Hansjuergen
    Lange, Clemens
    Hannibal, Luciana
    Bucher, Felicitas
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [6] The role of IL-6 in TBI and PTSD, a potential therapeutic target?
    Monsour, Molly
    Croci, Davide Marco
    Agazzi, Siviero
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2022, 218
  • [7] A Potential Role of IL-6/IL-6R in the Development and Management of Colon Cancer
    Turano, Mimmo
    Cammarota, Francesca
    Duraturo, Francesca
    Izzo, Paola
    De Rosa, Marina
    MEMBRANES, 2021, 11 (05)
  • [8] The role of IL-6 and IL-6 blockade in COVID-19
    Potere, Nicola
    Batticciotto, Alberto
    Vecchie, Alessandra
    Porreca, Ettore
    Cappelli, Antonella
    Abbate, Antonio
    Dentali, Francesco
    Bonaventura, Aldo
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (06) : 601 - 617
  • [9] IL-6 family cytokines as potential therapeutic strategies to treat metabolic diseases
    Zhao, Jingjing
    Turpin-Nolan, Sarah
    Febbraio, Mark A.
    CYTOKINE, 2021, 144
  • [10] Role of IL-6 and IL-6 targeted therapy in systemic lupus erythematosus
    Nepal, Desh
    Gazeley, David
    RHEUMATOLOGY, 2023, 62 (12) : 3804 - 3810